Anti‐tumor effects of a nonsteroidal anti‐inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator‐activated receptor gamma and suppressing matrix metalloproteinase‐2 expression

Abstract Surgical resection is the only treatment for chondrosarcomas, because of their resistance to chemotherapy and radiotherapy; therefore, additional strategies are crucial to treat chondrosarcomas. Peroxisome proliferator‐activated receptor gamma (PPARγ) is a ligand‐activated transcription fac...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Takashi Higuchi, Akihiko Takeuchi, Seiichi Munesue, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Hiroyuki Inatani, Shingo Shimozaki, Takashi Kato, Yu Aoki, Kensaku Abe, Yuta Taniguchi, Hisaki Aiba, Hideki Murakami, Ai Harashima, Yasuhiko Yamamoto, Hiroyuki Tsuchiya
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wiley 2018-05-01
סדרה:	Cancer Medicine
נושאים:	Chondrosarcoma MMP2 nonsteroidal anti‐inflammatory drugs PPAR γ zaltoprofen
גישה מקוונת:	https://doi.org/10.1002/cam4.1438
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!